← FDA Drug Approvals (Drugs@FDA)

MEDROXYPROGESTERONE ACETATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2004-10-27

Drug application

FDA Application #

ANDA076552

Application type

Abbreviated New Drug Application (Generic)

Brand name

MEDROXYPROGESTERONE ACETATE

Generic name

Medroxyprogesterone Acetate

Active ingredients

MEDROXYPROGESTERONE ACETATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

TEVA PHARMS USA

First approval

2004-10-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown